Clinical Trial Update: Research for Individualized Therapeutics in Rare Genetic Disease

View source ↗

Summary

Mayo Clinic is conducting a clinical trial to develop individualized therapeutics for rare genetic diseases, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rare Genetic Disease
• Undiagnosed Diseases

Snippet

Sponsor: Mayo Clinic | Conditions: Rare Genetic Disease, Undiagnosed Diseases | Status: ENROLLING_BY_INVITATION